Endo Tools Therapeutics (ETT) has taken a significant step in expanding access to advanced obesity care by partnering with Fujifilm Middle East FZE to introduce its endomina® platform across the Middle East and Africa. The endomina® system offers a novel, minimally invasive endoscopic approach to stomach volume reduction—performed orally without the need for external incisions. This technique supports weight loss by reducing gastric capacity and is tailored for patients who seek effective alternatives to bariatric surgery. By leveraging endoscopic suturing technology, endomina® enables a procedure that is both less invasive and highly adaptable, marking a meaningful innovation in obesity treatment.

This strategic partnership combines ETT’s cutting-edge medical technology with Fujifilm’s robust regional network and expertise in medical imaging and endoscopy. Through this collaboration, healthcare providers in the Middle East and Africa will gain access to a transformative treatment option amid rising obesity rates, where prevalence has reached over 21% in the region. Fujifilm’s strong distribution and support infrastructure will be instrumental in accelerating the deployment of the endomina® platform and ensuring successful clinical adoption across hospitals and health systems.

As obesity continues to drive increased rates of comorbidities such as diabetes and cardiovascular disease, scalable, patient-friendly solutions like endomina® are critical. The partnership between ETT and Fujifilm reflects a shared commitment to advancing care, improving outcomes, and expanding access to state-of-the-art therapeutic options. Together, they are poised to deliver meaningful impact in regions facing significant public health challenges, reinforcing the importance of global collaboration in the fight against obesity.